Navigation Links
Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Date:9/6/2007

>Velcade(R) (bortezomib) is a registered trademark of Millennium Pharmaceuticals, Inc.

Herceptin(R) (trastuzumab) is a registered trademark of Genentech, Inc.

Revlimid(R) (lenalidomide) is a registered trademark of Celgene Corporation

Cremophor(R) is a registered trademark of BASF Aktiengesellschaft


'/>"/>
SOURCE Kosan Biosciences Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
4. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
5. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
6. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
7. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
8. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
9. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
10. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
11. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... New York Times article ... Division," illustrates an internal renal community reimbursement debate ... be deprived of their life-saving immunosuppressive medications beyond ... Congress is poised to approve this urgent transplant ... kidney recipients, behind-the-scenes debate continues within the renal ...
(Date:12/15/2009)... Dec. 15 ,, Reportlinker.com announces ... available in its catalogue: ,, Hepatitis ... Forecasts to 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ... Analysis and Market Forecasts to 2015 ,, ... analysis specialist,s new report, "Hepatitis B Vaccines ...
(Date:12/15/2009)... Dec. 15 Waters Corporation (NYSE: ... Vision Publisher(TM) (v.7.1 SR4), an electronic laboratory notebook ... (SDMS), a secure electronic repository that stores and ... centralized database and is used to boost efficiency ... with the SAFE-BioPharma digital identity and signature standard. ...
Breaking Medicine Technology:AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 1Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 2Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 3Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 4Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 5Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 6Center for Medicines 26 Healthy Aging 28C 29 and BidRx 28R 29 Partner to Help Consumers Save on Prescription Medications 51986 1Center for Medicines 26 Healthy Aging 28C 29 and BidRx 28R 29 Partner to Help Consumers Save on Prescription Medications 51986 2Center for Medicines 26 Healthy Aging 28C 29 and BidRx 28R 29 Partner to Help Consumers Save on Prescription Medications 51986 3Potato Tops Poll To Be UKs National Veg 51985 1Potato Tops Poll To Be UKs National Veg 51985 2
... The Laboratory-Developed Test is Designed to Differentiate Squamous From, Non-Squamous Non-Small Cell Lung ... Percent and Specificity of 90 ... Percent., Accurate ... a Warning About Potential Higher Rates of Severe or Fatal Hemorrhage in ...
... April 3 ,Results of an independent multi-treatment ... first clinically proven non-invasive solution,for fat reduction ... will be presented at the American Society ... April 4, 2008 in Kissimmee, Florida. The,presentation ...
Other Medicine Technology:Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 2Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 3Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 4Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 5Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 6Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 7UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting 2UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting 3
(Date:12/15/2009)... 15 The Food and Health Bureau has ... overseas parties in developing private hospitals at four sites ... for submitting EOI is March 31, 2010. ,, ... Health, Dr. York Chow, said the promotion of private ... reform and a major Hong Kong government policy announced ...
(Date:12/15/2009)... coal for lying about taxes in the healthcare bill ... has earned a place under the "Naughty" column on Americans ... after being caught telling a brazen lie on the floor ... bill would not raise taxes. ,, Speaking on the ... " I have also heard it ...
(Date:12/15/2009)... Our Lady of Lourdes Health Care Services ... has agreed to pay the United States $7.95 million ... Justice Department announced today. The two hospitals are Our ... and Lourdes Medical Center of Burlington County (LMC) in ... a suit brought by a whistleblower, Tony Kite, in ...
(Date:12/15/2009)... reproductive age were evaluated, Italian study found , , TUESDAY, ... born with cystic fibrosis decreases when screening for potential ... new study finds. , CF neonatal screening has been ... years. Since the 1990s, the area has seen a ... with CF. , Two different CF carrier detection methods ...
(Date:12/15/2009)... really been in trouble, expert says , , TUESDAY, Dec. ... H1N1 swine flu has revealed serious flaws in the ... new report says. , The report, prepared by the ... Foundation, also finds the dire economy has strained the ... outbreak is the latest in a series of reminders ...
Breaking Medicine News(10 mins):Health News:Hong Kong Government Invites Expressions of Interest in Development of Private Hospitals 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3
... 19 RRY Publications today announced,that several stem ... biology and general medicine services (oncology) at Case ... director of the W.M. Keck,Center for Collaborative Neuroscience ... New Jersey, Thomas R. Lyon, M.D., the chief ...
... Accenx Technologies, Inc., a,leading company in electronic ... solutions, announced today the launch of their,new Physician,s ... their,clients, such as large health systems, hospitals, and ... outreach programs, and connect,physician practices to RyTRAK HIE ...
... Calif., Feb. 19 Accenx Technologies, Inc., ... interoperability and,health data integration solutions, announced today ... HIMSS 2008 Interoperability Showcases, located in,the Interoperability ... Orange,County Convention Center., The 2008 Interoperability ...
... winter day and you will see the water vapor coming ... Nobel-Prize-related tool, and you could potentially detect trace amounts of ... of disease. In a new paper,* a team led by ... the National Institute of Standards and Technology (NIST) and the ...
... focusing on Communication, Technical and Soft Skills ... Convenient Online Delivery, CLIFTON PARK, N.Y., Feb. 19 ... announce the release of Milady U, a complete,offering of ... industry.,Milady U teaches real-world skills to advance the careers ...
... have served up chicken soup to remedy the common cold, ... as well. Researchers at the National Institute of Standards and ... research firm SAIC recently showed how chicken antibodies may one ... cancer. , HER2 is one of a family of genes ...
Other Medicine News:Health News:Stem Cell Experts and New York Lt. Gov. David Paterson to Participate in 3rd Annual Stem Cell Summit as Keynote Speakers 2Health News:Stem Cell Experts and New York Lt. Gov. David Paterson to Participate in 3rd Annual Stem Cell Summit as Keynote Speakers 3Health News:New Accenx Physician's Relations Department! Now At Your Service 2Health News:Accenx Technologies Brings Healthcare IT Solutions to HIMSS08 Interoperability Showcase 2Health News:Optical 'frequency comb' can detect the breath of disease 2Health News:Milady U Provides Continuing Education to Salon and Spa Professionals 2Health News:NIST, NCI, SAIC partner on new method for detecting HER2 breast cancer 2
... capture the patient`s exhaled heat and moisture ... Small and compact, they are specially treated ... on the tidal volume requirements, select either ... adult HCH is ideal for patient tidal ...
Combination heat and moisture exchanger and bacterial/viral filters for Anesthesia and Respiratory applications....
Combination heat and moisture exchanger and bacterial/viral filters for Anesthesia and Respiratory applications....
HME only...
Medicine Products: